细胞淋巴瘤-话题@MedSci

#细胞淋巴瘤#

385篇内容 | 5338人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702435, encodeId=fc551e02435bb, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=套细胞淋巴瘤诊断与治疗中国专家共识（2016版）解读, objectType=article, longId=115688, objectId=c71411568885, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c71411568885, replyNumber=0, likeNumber=43, createdTime=2018-09-21, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c71411568885, moduleTitle=套细胞淋巴瘤诊断与治疗中国专家共识（2016版）解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c71411568885)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702463, encodeId=4ed41e02463f0, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）, objectType=article, longId=128660, objectId=42e21286605a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e21286605a, replyNumber=0, likeNumber=17, createdTime=2018-03-15, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e21286605a, moduleTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42e21286605a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702457, encodeId=2a1e1e0245779, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：PI3K-δ/γ抑制剂duvelisib用于T细胞淋巴瘤的活性。, objectType=article, longId=123385, objectId=165a123385bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=165a123385bf, replyNumber=0, likeNumber=63, createdTime=2018-02-18, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=165a123385bf, moduleTitle=Blood：PI3K-δ/γ抑制剂duvelisib用于T细胞淋巴瘤的活性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=165a123385bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702492, encodeId=24a71e024922a, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：Brentuximab Vedotin+CHP一线治疗外周T细胞淋巴瘤5年结局喜人：客观反应率高达100%！, objectType=article, longId=138647, objectId=e39113864ec6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e39113864ec6, replyNumber=0, likeNumber=61, createdTime=2018-06-23, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e39113864ec6, moduleTitle=Blood：Brentuximab Vedotin+CHP一线治疗外周T细胞淋巴瘤5年结局喜人：客观反应率高达100%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e39113864ec6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702501, encodeId=8d0b1e025018f, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, objectType=article, longId=145217, objectId=49aa14521efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49aa14521efb, replyNumber=0, likeNumber=85, createdTime=2019-06-05, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49aa14521efb, moduleTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49aa14521efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702486, encodeId=38bc1e02486ff, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗, objectType=article, longId=137081, objectId=3c9113e08130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c9113e08130, replyNumber=0, likeNumber=75, createdTime=2018-07-07, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c9113e08130, moduleTitle=【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c9113e08130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702470, encodeId=c9001e0247052, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：T细胞淋巴瘤（2018.V3）, objectType=article, longId=131494, objectId=c70113149432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c70113149432, replyNumber=0, likeNumber=17, createdTime=2018-12-15, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c70113149432, moduleTitle=NCCN临床实践指南：T细胞淋巴瘤（2018.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c70113149432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702458, encodeId=54121e02458bb, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=张会来教授：外周T细胞淋巴瘤和NK/T细胞淋巴瘤的研究进展, objectType=article, longId=124109, objectId=73a712410935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73a712410935, replyNumber=0, likeNumber=75, createdTime=2018-05-07, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73a712410935, moduleTitle=张会来教授：外周T细胞淋巴瘤和NK/T细胞淋巴瘤的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73a712410935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702479, encodeId=443a1e0247901, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）, objectType=article, longId=134134, objectId=96e713413423, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96e713413423, replyNumber=0, likeNumber=24, createdTime=2018-07-20, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96e713413423, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96e713413423)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702483, encodeId=91211e024839f, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V3）, objectType=article, longId=136397, objectId=50dc13639e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50dc13639e81, replyNumber=0, likeNumber=37, createdTime=2018-12-08, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50dc13639e81, moduleTitle=NCCN临床实践指南：B细胞淋巴瘤（2018.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50dc13639e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702480, encodeId=6e291e02480cc, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NEJM：伊布替尼联合维奈妥拉可显著改善复发难治性套细胞淋巴瘤预后, objectType=article, longId=134263, objectId=786e13426328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=786e13426328, replyNumber=0, likeNumber=55, createdTime=2018-08-20, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=786e13426328, moduleTitle=NEJM：伊布替尼联合维奈妥拉可显著改善复发难治性套细胞淋巴瘤预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=786e13426328)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702491, encodeId=46241e02491bd, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：RhoA G17V突变可促进形成具有滤泡辅助T细胞特性的T细胞淋巴瘤, objectType=article, longId=138446, objectId=305b13844696, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=305b13844696, replyNumber=0, likeNumber=71, createdTime=2018-10-01, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=305b13844696, moduleTitle=Blood：RhoA G17V突变可促进形成具有滤泡辅助T细胞特性的T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=305b13844696)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702441, encodeId=e95b1e024411b, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V2）, objectType=article, longId=119201, objectId=1e6e119201f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e6e119201f2, replyNumber=0, likeNumber=20, createdTime=2018-09-15, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e6e119201f2, moduleTitle=NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e6e119201f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702452, encodeId=19a91e0245243, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V1）, objectType=article, longId=123111, objectId=e22d123111ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e22d123111ab, replyNumber=0, likeNumber=28, createdTime=2018-06-06, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e22d123111ab, moduleTitle=NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e22d123111ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702462, encodeId=c2c41e0246224, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, objectType=article, longId=128600, objectId=c14a1286000a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14a1286000a, replyNumber=0, likeNumber=74, createdTime=2018-11-10, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14a1286000a, moduleTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14a1286000a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702469, encodeId=01d81e02469c0, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, objectType=article, longId=130819, objectId=73341308194e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73341308194e, replyNumber=0, likeNumber=65, createdTime=2018-08-03, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73341308194e, moduleTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73341308194e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702448, encodeId=e8271e02448ee, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=【ASH 2017】利妥昔单抗时代首次缓解后自体造血干细胞移植巩固治疗可以提高年轻套细胞淋巴瘤患者总生存, objectType=article, longId=121505, objectId=d3211215052f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3211215052f, replyNumber=0, likeNumber=66, createdTime=2018-08-06, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3211215052f, moduleTitle=【ASH 2017】利妥昔单抗时代首次缓解后自体造血干细胞移植巩固治疗可以提高年轻套细胞淋巴瘤患者总生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3211215052f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702444, encodeId=21d71e02444ee, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。, objectType=article, longId=120438, objectId=26471204387a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26471204387a, replyNumber=0, likeNumber=53, createdTime=2018-03-02, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26471204387a, moduleTitle=Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26471204387a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702438, encodeId=38ad1e024384e, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=JAMA Surg：乳房植入相关的间变性大细胞淋巴瘤的特征及治疗, objectType=article, longId=117565, objectId=5d1611e5651d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d1611e5651d, replyNumber=0, likeNumber=72, createdTime=2018-07-24, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d1611e5651d, moduleTitle=JAMA Surg：乳房植入相关的间变性大细胞淋巴瘤的特征及治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d1611e5651d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702415, encodeId=cf621e0241558, content=<a href='/topic/show?id=ddc9e795159' target=_blank style='color:#2F92EE;'>#细胞淋巴瘤#</a>, objectTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, objectType=article, longId=104214, objectId=35571042148f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35571042148f, replyNumber=0, likeNumber=58, createdTime=2017-12-25, rootId=0, userName=marlenexl, userId=201630414353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35571042148f, moduleTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35571042148f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞淋巴瘤

2020-05-29

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

套细胞淋巴瘤诊断与治疗中国专家共识（2016版）解读

2018-09-21

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V2）

2018-03-15

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：PI3K-δ/γ抑制剂duvelisib用于T细胞淋巴瘤的活性。

2018-02-18

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：Brentuximab Vedotin+CHP一线治疗外周T细胞淋巴瘤5年结局喜人：客观反应率高达100%！

2018-06-23

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变

2019-06-05

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

【重磅】厉害了！FDA批准Kymriah用于复发/难治大B细胞淋巴瘤治疗

2018-07-07

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：T细胞淋巴瘤（2018.V3）

2018-12-15

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

张会来教授：外周T细胞淋巴瘤和NK/T细胞淋巴瘤的研究进展

2018-05-07

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V5）

2018-07-20

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：B细胞淋巴瘤（2018.V3）

2018-12-08

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NEJM：伊布替尼联合维奈妥拉可显著改善复发难治性套细胞淋巴瘤预后

2018-08-20

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：RhoA G17V突变可促进形成具有滤泡辅助T细胞特性的T细胞淋巴瘤

2018-10-01

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（2018.V2）

2018-09-15

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

NCCN临床实践指南：原发性皮肤B细胞淋巴瘤（2018.V1）

2018-06-06

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果

2018-11-10

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？

2018-08-03

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

【ASH 2017】利妥昔单抗时代首次缓解后自体造血干细胞移植巩固治疗可以提高年轻套细胞淋巴瘤患者总生存

2018-08-06

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

Blood：罗米地辛与普拉曲沙的联合治疗难治性/复发性T细胞淋巴瘤可获得高反应率。

2018-03-02

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

JAMA Surg：乳房植入相关的间变性大细胞淋巴瘤的特征及治疗

2018-07-24

marlenexl (审核中...)

前往app查看评论内容

#细胞淋巴瘤#

SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！

2017-12-25

科室
- - 订阅+
  - 更多科室
工具
服务